GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wuhan Hiteck Biological Pharma Co Ltd (SZSE:300683) » Definitions » Net Margin %

Wuhan Hiteck Biological Pharma Co (SZSE:300683) Net Margin % : -12.55% (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Wuhan Hiteck Biological Pharma Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Wuhan Hiteck Biological Pharma Co's Net Income for the three months ended in Mar. 2024 was ¥-16.5 Mil. Wuhan Hiteck Biological Pharma Co's Revenue for the three months ended in Mar. 2024 was ¥131.9 Mil. Therefore, Wuhan Hiteck Biological Pharma Co's net margin for the quarter that ended in Mar. 2024 was -12.55%.

The historical rank and industry rank for Wuhan Hiteck Biological Pharma Co's Net Margin % or its related term are showing as below:

SZSE:300683' s Net Margin % Range Over the Past 10 Years
Min: -22.82   Med: 11.22   Max: 20.37
Current: -22.82


SZSE:300683's Net Margin % is ranked worse than
73.9% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 3.06 vs SZSE:300683: -22.82

Wuhan Hiteck Biological Pharma Co Net Margin % Historical Data

The historical data trend for Wuhan Hiteck Biological Pharma Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Hiteck Biological Pharma Co Net Margin % Chart

Wuhan Hiteck Biological Pharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.16 -4.77 4.50 -2.04 -20.06

Wuhan Hiteck Biological Pharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.06 -6.53 -10.08 -57.60 -12.55

Competitive Comparison of Wuhan Hiteck Biological Pharma Co's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Wuhan Hiteck Biological Pharma Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuhan Hiteck Biological Pharma Co's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wuhan Hiteck Biological Pharma Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Wuhan Hiteck Biological Pharma Co's Net Margin % falls into.



Wuhan Hiteck Biological Pharma Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Wuhan Hiteck Biological Pharma Co's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-120.823/602.284
=-20.06 %

Wuhan Hiteck Biological Pharma Co's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-16.546/131.888
=-12.55 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wuhan Hiteck Biological Pharma Co  (SZSE:300683) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Wuhan Hiteck Biological Pharma Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Wuhan Hiteck Biological Pharma Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuhan Hiteck Biological Pharma Co (SZSE:300683) Business Description

Traded in Other Exchanges
N/A
Address
Hite Science and Technology Park, Wuhan Economic and Technological Development Zone, Hubei Province, Wuhan, CHN, 430056
Wuhan Hiteck Biological Pharma Co Ltd is a biopharmaceutical manufacturing enterprise in China. The company is primarily engaged in the development, production and sale of biological products. Its product portfolio comprises rat nerve growth factor freeze-dried powder injection, injection of anti-hepatitis B transfer factor freeze-dried powder injection, thrombin and other chemicals. The company also has more than 20 kinds of products such as hepatitis B treatment drug op Heparin and hemostatic agent thrombin.
Executives
Yan Jie Director
Li Sheng Qiang Executives

Wuhan Hiteck Biological Pharma Co (SZSE:300683) Headlines

No Headlines